跳至主要内容
临床试验/CTIS2024-512844-40-00
CTIS2024-512844-40-00进行中(未招募)1 期

Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial - ProFET

Vaestra Goetalandsregionen0 个研究点目标入组 1,800 人开始时间: 2024年6月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Planned for a FET-NC with a blastocyst, Age=18<43 years, BMI=18.5<35, Regular menstrual cycles 24-35 days, Given informed consent, Understand written and spoken Swedish, English or Arabic

排除标准

  • ART-related: Oocyte donor cycles. Preimplantation Genetic Testing (PGT) cycles. Uterine malformation, precluding cervical access to the uterine cavity. Submucous myoma and endometrial polyps requiring surgery before transfer of embryo., Drug-related: Hypersensitivity against study medication. Other contraindications according to FASS: Undiagnosed vaginal bleeding, severely impaired liver function or liver disease, known or suspected malignancy of breast or genital region, ongoing arterial or venous thromboembolism, porphyria or history of these conditions (FASS.se)., Development of serious disease contraindicating ART or pregnancy., Participation or recent participation in a clinical study with an investigational product (during the past 30 days). Previous participation in this study.

研究者

发起方
Vaestra Goetalandsregionen

相似试验